Kandi Technologies Group enters the week trading at $0.70 — but the real story is a compliance clock now ticking loudly in the background.
On May 5, the company received a Nasdaq minimum bid price deficiency notice. At $0.70, the stock is well below the $1.00 threshold required for continued listing. Kandi now has until November 2 to regain compliance, through a reverse split, a sustained price recovery, or both. That deadline reframes almost every other datapoint in this note.
The lending market is notably relaxed given the circumstances. Short interest runs at roughly 2% of the free float — low enough that short sellers are not the story here. Borrow costs have actually eased over the past month, down around 8%, to a barely punitive 0.55%. Availability is abundant at 369% of short interest, meaning shares to borrow vastly outnumber those already borrowed. The ORTEX short score has dropped sharply this week, falling from around 49 to 45, as availability loosened and days-to-cover remained modest. This is not a stock where bears are pressing a crowded thesis. The real pressure on the stock is fundamental, not structural.
Options tell a similar story of disengagement. The put/call ratio is pinned near the floor at 0.026, barely off its 52-week low of 0.013, and well below any reading that would indicate active hedging. The 52-week high on the PCR was 0.87 — the gap between that peak and the current level underscores just how thin options activity has become. Traders are not paying for downside protection, partly because there is little open interest to protect.
The earnings backdrop is grim. When Kandi reported full-year 2025 results on April 28, it posted EPS of -$1.12, worse than the -$0.59 loss the prior year, while revenue fell to $87.4M from $127.6M. The stock dropped nearly 4% the day after that release. A five-day recovery of about 2% followed, but the stock has since resumed its slide, now down 15% over the past month. Late April also brought a 2026–2030 strategic development framework from management, including a CEO shareholder letter. Neither appears to have shifted investor sentiment. Next earnings are scheduled for May 19 — less than two weeks away — and this time the backdrop includes an active compliance deficiency.
Institutional ownership is thin and concentrated. Chairman and President/CEO Xiaoming Hu holds 17.4% of shares, leaving the remaining institutional base quite small. Among financial institutions, the largest holder is Susquehanna with fewer than 250,000 shares; Citadel, Renaissance, and Bridgeway each hold fractions of a percent. Total institutional holders number just 22 — a figure that reflects the company's micro-cap status (market cap near $58M) and its current position near the bottom of Nasdaq's listing requirements. The RSI14 has drifted to 36, approaching oversold territory, but technical signals carry limited weight ahead of a catalyst-heavy two weeks.
The May 19 print is therefore less about whether Kandi can outline a recovery path and more about whether the quarterly trajectory gives any credibility to a compliance timeline that now runs to November.
See the live data behind this article on ORTEX.
Open KNDI on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
